Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Iatrogenic amnesia is one of the main aetiologies of transient amnesia. • Benzodiazepines and anticholinergic drugs are considered to be the drugs most often responsible for iatrogenic amnesia. • The impact of drugs in memory disorders is particularly pronounced in elderly people, especially due to polymedication. WHAT THIS STUDY ADDS • An association between memory disorders and some drugs, such as benzodiazepines, antidepressants and older anticonvulsants, was found as expected. • A strong association was found with unexpected drugs, such as benzodiazepine‐like hypnotics (zopiclone and zolpidem), serotonin reuptake inhibitor antidepressants and newer anticonvulsants. • Non‐neurotropic drugs, such as isotretinoin and ciclosporin, were also associated with memory disorders. AIMS To investigate putative associations of reports of memory disorders and suspected drugs. METHODS We used the case/noncase method in the French PharmacoVigilance Database (FPVD). Cases were reports of memory loss in the FPVD between January 2000 and December 2009. Noncases were all other reports during the same period. To assess the association between memory impairment and drug intake, we calculated an odds ratio with its 95% confidence interval. RESULTS Among the 188 284 adverse drug reactions recorded, we identified 519 cases of memory loss. The sex ratio was 0.6 and the median age was 54 years (range 4–93). The maximal number of cases occurred between 40–49 and 50–59 years. Evolution was favourable in 63% of the cases. We found significant odds ratios for benzodiazepines (alprazolam, bromazepam, prazepam, clonazepam etc.), benzodiazepine‐like hypnotics (zolpidem and zopiclone), antidepressants (fluoxetine, paroxetine and venlafaxine), analgesics (morphine, nefopam and tramadol), anticonvulsants (topiramate, pregabalin, levetiracetam etc.), antipsychotics (aripiprazole and lithium) and other drugs, such as trihexyphenidyl, ciclosporin and isotretinoin. CONCLUSIONS Our study confirmed an association between memory disorders and some drugs, such as benzodiazepines and anticonvulsants. However, other drugs, such as benzodiazepine‐like hypnotics, newer anticonvulsants, serotonin reuptake inhibitor antidepressants, isotretinoin and ciclosporin were significantly associated with memory disorders, although this was not described or poorly described in the literature. Taking account of the limits of this study in the FPVD (under‐reporting, notoriety bias etc.), the case/noncase method allows assessment and detection of associations between exposure to drugs and a specific adverse drug reaction, such as memory disorders, and could thus generate signals and orientate us to further prospective studies to confirm such associations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotransmitter Receptor and Transporter Binding Profile of Antidepressants and Their Metabolites
Owens, M. J., Morgan, W. N., Plott, S. J., & Nemeroff, C. B. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37161-7 · Cited by 676
Ancelin, M. L., Artero, S., Portet, F., Dupuy, A.-M., Touchon, J., & Ritchie, K. (2006) · BMJ · doi:10.1136/bmj.38740.439664.de · Cited by 589
GABA-based therapeutic approaches: GABAA receptor subtype functions
RUDOLPH, U., & MOHLER, H. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.10.003 · Cited by 499
Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
Hyttel, J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00004 · Cited by 492
Effects of antidepressants on cognitive functions: a review
Amado-Boccara, I. (1995) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)00068-c · Cited by 206
FONTAINE, R., BEAUDRY, P., MORVAN, P. L., BEAUCLAIR, L., & CHOUINARD, G. (1990) · International Clinical Psychopharmacology · doi:10.1097/00004850-199007000-00002 · Cited by 37
Cited by
Montastruc, J., Sommet, A., Bagheri, H., & Lapeyre‐Mestre, M. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04037.x · Cited by 517
Gastaldon, C., Raschi, E., Kane, J. M., Barbui, C., & Schoretsanitis, G. (2021) · Psychotherapy and Psychosomatics · doi:10.1159/000510703 · Cited by 134
Benzodiazepine use and aggressive behaviour: a systematic review
Albrecht, B., Staiger, P. K., Hall, K., Miller, P., Best, D., & Lubman, D. I. (2014) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867414548902 · Cited by 87
“Such examination is especially pertinent, with increasing evidence that amnesia is a common consequence of benzodiazepine use (e.g. Chavant et al., 2011; Dåderman et al., 2003; Tannenbaum et al., 2012), which, when coupled with their afore-mentioned disinhibitory properties, may lead to…”
Background
Metadata
- Authors
- Chavant, F., Favrelière, S., Lafay‐Chebassier, C., Plazanet, C., & Pérault‐Pochat, M.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2011-11-09
- Volume
- 72
- Issue
- 6
- Pages
- 898-904
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W1522048482
- Cited by
- 92
- References
- 6
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database. https://app.cochat.ai/papers/10.1111/j.1365-2125.2011.04009.x
- The paper
- Chavant, F., Favrelière, S., Lafay‐Chebassier, C., Plazanet, C., & Pérault‐Pochat, M. (2011). Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2011.04009.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.